Caplan M S, Kelly A, Hsueh W
Department of Pediatrics, Evanston Hospital, Illinois 60201.
Pediatr Res. 1992 May;31(5):428-34. doi: 10.1203/00006450-199205000-00002.
We have previously shown that intravascular platelet activating factor (PAF) causes ischemic bowel necrosis in rats morphologically similar to neonatal necrotizing enterocolitis (NEC). Because endotoxin (LPS) and hypoxia are risk factors for NEC, we studied their effect on PAF metabolism and the development of intestinal injury. Young male Sprague-Dawley rats were anesthetized with pentobarbital and divided into six experimental groups: 1) control, 2) LPS alone (2 mg/kg), 3) hypoxia alone (5% O2), 4) LPS+hypoxia, 5) WEB 2086 (PAF antagonist)+LPS+hypoxia, and 6) SRI 63-441 (PAF antagonist)+LPS+hypoxia. Evaluations included blood pressure recording, superior mesenteric artery blood flow, arterial blood gas, white blood cell count, hematocrit, plasma PAF, plasma acetylhydrolase, plasma tumor necrosis factor, intestinal perfusion, and intestinal injury at 3 h. We found that LPS+hypoxia synergistically contributed to hypotension (mean blood pressure 27 +/- 5.6% baseline versus 101 +/- 3.9% control), metabolic acidosis (pH 7.05, base deficit 24 mEq/L), hemoconcentration, decreased superior mesenteric artery blood flow (2.2 +/- 0.3 mL/min versus 5.8 +/- 0.2 mL/min control), and intestinal injury. The morbidities resulting from LPS+hypoxia were partially or completely prevented by PAF antagonists. In addition, animals treated with LPS+hypoxia had neutropenia, elevated plasma acetylhydrolase, and elevated plasma TNF. These results suggest that endogenous PAF may contribute to LPS+hypoxia-induced intestinal hypoperfusion and necrosis.
我们之前已经表明,血管内血小板活化因子(PAF)可导致大鼠出现形态学上与新生儿坏死性小肠结肠炎(NEC)相似的缺血性肠坏死。由于内毒素(LPS)和缺氧是NEC的危险因素,我们研究了它们对PAF代谢及肠道损伤发展的影响。将幼年雄性Sprague-Dawley大鼠用戊巴比妥麻醉,并分为六个实验组:1)对照组,2)单独使用LPS(2mg/kg),3)单独缺氧(5% O₂),4)LPS+缺氧,5)WEB 2086(PAF拮抗剂)+LPS+缺氧,6)SRI 63-441(PAF拮抗剂)+LPS+缺氧。评估内容包括血压记录、肠系膜上动脉血流量、动脉血气、白细胞计数、血细胞比容、血浆PAF、血浆乙酰水解酶、血浆肿瘤坏死因子、肠道灌注以及3小时时的肠道损伤情况。我们发现,LPS+缺氧协同导致低血压(平均血压为基线的27±5.6%,而对照组为101±3.9%)、代谢性酸中毒(pH 7.05,碱缺失24mEq/L)、血液浓缩、肠系膜上动脉血流量减少(2.2±0.3mL/min,而对照组为5.8±0.2mL/min)以及肠道损伤。PAF拮抗剂可部分或完全预防LPS+缺氧导致的发病率。此外,接受LPS+缺氧处理的动物出现中性粒细胞减少、血浆乙酰水解酶升高以及血浆TNF升高。这些结果表明,内源性PAF可能导致LPS+缺氧诱导的肠道灌注不足和坏死。